ClinicalTrials.Veeva

Menu

Efficacy of Snap on Symptomatic Arrhythmia

N

Nanjing Medical University

Status

Unknown

Conditions

Arrhythmia

Treatments

Diagnostic Test: Snap

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Participants in the Snap arm were instructed to undertake once-day recording and transmission of a 30-second single-lead iECG trace to a secure server, plus additional submissions if symptomatic over a 3-month period. Snap traces were analyzed by an automated analysis software and cardiologists. Clinical review and appropriate care was arranged for those clinically significant arrhythmia. Patients in the RC group were followed up as normal methods including ECG, Holter.

Full description

Individuals with symptomatic arrhythmia without known arrhythmia were recruited.

Participants were required to have access to the internet via WiFi and to be able to operate the Snap system after simple instruction. Written consent was obtained, and eligible participants were randomized (1:1) to an intervention (Snap) group or RC group.

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • symptomatic arrhythmia

Exclusion criteria

  • can not use the Snap instrument and Sign informed consent

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

120 participants in 2 patient groups

Snap group
Experimental group
Description:
individuals in this arm used Snap according to the instruction on time and screened at the symptomatic
Treatment:
Diagnostic Test: Snap
RC group
No Intervention group
Description:
patients in the RC arm accepted normal methods

Trial contacts and locations

2

Loading...

Central trial contact

Jin-Shuang Li, MD; Chun-Jian Li, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems